Sort
50,496 grants matching “lung cancer”
Project 2: Combined CAR-T cell therapy
$433,764Gianpietro Dotti · Univ Of North Carolina Chapel Hill · P50 · FY2022 · CA
Targeting LKB1-null lung adenocarcinoma with innate immune system
$433,754Wei Zhou · Emory University · R01 · FY2025 · CA
Developmental Funds
$433,659Steven E Artandi · Stanford University · P30 · FY2023 · CA
Developmental Funds
$433,659Steven E Artandi · Stanford University · P30 · FY2024 · CA
Developmental Funds
$433,659Steven E Artandi · Stanford University · P30 · FY2022 · CA
Human T Cell Responses to Tumor Antigens for Cancer Vaccine Development
$433,644Jeffrey Schlom · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
Accountability for Cancer Care through Undoing Racism and Equity (ACCURE)
$433,633Eugenia Eng · Univ Of North Carolina Chapel Hill · R01 · FY2016 · CA
Genetic Mechanisms Regulating Hypoxia Tolerance in the Brain
$433,595Gabriel G Haddad · University Of California, San Diego · R21 · FY2020 · NS
Structural Mechanisms of Hedgehog Autoprocessing in Physiology and Disease
$433,541Chunyu Wang · Rensselaer Polytechnic Institute · R01 · FY2020 · CA
Structural Mechanisms of Hedgehog Autoprocessing in Physiology and Disease
$433,541Chunyu Wang · Rensselaer Polytechnic Institute · R01 · FY2021 · CA
Lung transplant recipient exosome phenotypes and the risk of primary graft dysfunction and acute lung allograft dysfunction
$433,531Michael Scott Mulligan · University Of Washington · U01 · FY2025 · HL
Technologies and Resources for Core Laboratories
$433,529Laura F Gibson · West Virginia University · U54 · FY2018 · GM
Targeting hTERT/telomerase for managing acquired resistance to third generation EGFR-TKIs in lung cancer
$433,505Shi-Yong Sun · Emory University · R01 · FY2024 · CA
Mechano-regulation of bone metastatic cancer: linking cell strain to cell function
$433,500Maureen E Lynch · University Of Massachusetts Amherst · · FY2016 · ENG
Role of CHI3L1 in accelerating breast cancer metastasis: a mechanistic approach
$433,500Vijaya L Iragavarapu-Charyulu · Florida Atlantic University · R15 · FY2012 · CA
Modulation of Mcl-1 for Treatment of Lung Cancer
$433,488Xingming Deng · Emory University · R01 · FY2021 · CA
Study of Interleukin 33 as a new immunotherapy of lung cancer
$433,485Binfeng Lu · Hackensack University Medical Center · R01 · FY2023 · CA
A Multi-omics evaluation of Carfilzomib-related Cardiotoxicity
$433,446Yan Gong · University Of Florida · R01 · FY2021 · HL
Targeting tumor-neural cell interactions to inhibit lung cancer brain metastasis
$433,375Ann Marie Pendergast · Duke University · R01 · FY2021 · CA
Translational Control in IPF
$433,366Peter B Bitterman · University Of Minnesota · R01 · FY2010 · HL
Lung Cancer Vaccine
$433,293Steven Monroe Lipkin · Weill Medical Coll Of Cornell Univ · U54 · FY2024 · CA
Residual disease: unraveling immunosurveillance and immune evasion of disseminated tumor cells
$433,277Joan Massague · Sloan-Kettering Inst Can Research · U54 · FY2020 · CA
Biomolecular Analysis using Liquid Crystals
$433,274Nicholas L Abbott · University Of Wisconsin-Madison · R01 · FY2007 · CA
Overcoming resistance to KRAS inhibitors through a fragment-based chemoproteomics approach
$433,256Eric B. Haura · H. Lee Moffitt Cancer Ctr & Res Inst · R21 · FY2023 · CA
VIRGINIA MASON COMMUNITY CLINICAL ONCOLOGY PROGRAM
$433,245Benaroya Research Inst At Virginia Mason · U10 · FY2003 · CA